Evaluation CAPES Module #2: Understanding and Managing Pain and Fatigue in SpA and PsA

Demographic Questions

Question Title

* 1. Please provide your name and email address.

Name

Email Address

Question Title

* 2. What is your specialty?

Dermatology

Rheumatology

Primary Care

Other (please specify)

Question Title

* 3. Please indicate your practice setting.

Academic

Community

Question Title

* 4. Number of patients seen/impacted per week.

Activity Objectives: Please rate your level of achievement.

Question Title

* 5. Understand the neurobiology of pain processing.

Outstanding

Good

Average

Fair

Poor

Question Title

* 6. Explain the assessment of pain in clinical trials and clinical practices.

Outstanding

Good

Average

Fair

Poor

Question Title

* 7. Examine the impact of central sensitization and fibromyalgia on pain assessments and outcomes in PsA and axSpA.

Outstanding

Good

Average

Fair

Poor

Question Title

* 8. Examine why fatigue is a “core” outcome in rheumatic diseases including psoriatic arthritis.

Outstanding

Good

Average

Fair

Poor

Question Title

* 9. Review what may cause fatigue.

Outstanding

Good

Average

Fair

Poor

Question Title

* 10. Identify ways to assess fatigue.

Outstanding

Good

Average

Fair

Poor

Question Title

* 11. Examine how to treat fatigue.

Outstanding

Good

Average

Fair

Poor

Evaluation of the Presenters

Question Title

* 12. The content of the presentation given by Melissa Leeolou was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 13. The delivery of the presentation given by Melissa Leeolou was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 14. Did Melissa Leeolou appear objective and unbiased by commercial interests?

Yes

If no, please explain:

Question Title

* 15. The content of the presentation given by Minionette “Mini” Wilson was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 16. The delivery of the presentation given by Minionette “Mini” Wilson was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 17. Did Minionette “Mini” Wilson appear objective and unbiased by commercial interests?

Yes

If no, please explain:

Question Title

* 18. The content of the presentation given by Philip Mease, MD, was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 19. The delivery of the presentation given by Philip Mease, MD, was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 20. Did Philip Mease, MD, appear objective and unbiased by commercial interests?

Yes

If no, please explain:

Question Title

* 21. The content of the presentation given by Ernest Choy, MD, FRCP (UK), was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 22. The delivery of the presentation given by Ernest Choy, MD, FRCP (UK), was:

Outstanding

Good

Average

Fair

Poor

Question Title

* 23. Did Ernest Choy, MD, FRCP (UK), appear objective and unbiased by commercial interests?

Yes

If no, please explain:

Question Title

* 24. As a moderator, Philip Mease, MD, was:

Outstanding

Good

Average

Fair

Poor

Relevance and Application

Question Title

* 25. Was the information in this activity relevant to your practice or professional development?

Yes

Question Title

* 26. I learned new information about SpA and PsA as a result of this program.

Yes

Question Title

* 27. Based on the information you received today, do you plan on changing your practice?

Yes, I intend to change the therapy that I render

Yes, I intend to alter the way that I evaluate my patients

Yes, I intend to change the legal/documentation/financial management of my practice

Yes, it may affect my patient referrals

No, but it did confirm my current practice

No, because it doesn’t directly apply to my practice

No, but it did increase my knowledge of community resources

No, because the information was inadequate and/or inaccurate

Other (please elaborate)

Question Title

* 28. How would you rate the presentation overall?

Outstanding

Good

Average

Fair

Poor

Evaluation CAPES Module #2: Understanding and Managing Pain and Fatigue in SpA and PsA

Question Title

* 1. Please provide your name and email address.

Question Title

* 2. What is your specialty?

Question Title

* 3. Please indicate your practice setting.

Question Title

* 4. Number of patients seen/impacted per week.

Question Title

* 5. Understand the neurobiology of pain processing.

Question Title

* 6. Explain the assessment of pain in clinical trials and clinical practices.

Question Title

* 7. Examine the impact of central sensitization and fibromyalgia on pain assessments and outcomes in PsA and axSpA.

Question Title

* 8. Examine why fatigue is a “core” outcome in rheumatic diseases including psoriatic arthritis.

Question Title

* 9. Review what may cause fatigue.

Question Title

* 10. Identify ways to assess fatigue.

Question Title

* 11. Examine how to treat fatigue.

Question Title

* 12. The content of the presentation given by Melissa Leeolou was:

Question Title

* 13. The delivery of the presentation given by Melissa Leeolou was:

Question Title

* 14. Did Melissa Leeolou appear objective and unbiased by commercial interests?

Question Title

* 15. The content of the presentation given by Minionette “Mini” Wilson was:

Question Title

* 16. The delivery of the presentation given by Minionette “Mini” Wilson was:

Question Title

* 17. Did Minionette “Mini” Wilson appear objective and unbiased by commercial interests?

Question Title

* 18. The content of the presentation given by Philip Mease, MD, was:

Question Title

* 19. The delivery of the presentation given by Philip Mease, MD, was:

Question Title

* 20. Did Philip Mease, MD, appear objective and unbiased by commercial interests?

Question Title

* 21. The content of the presentation given by Ernest Choy, MD, FRCP (UK), was:

Question Title

* 22. The delivery of the presentation given by Ernest Choy, MD, FRCP (UK), was:

Question Title

* 23. Did Ernest Choy, MD, FRCP (UK), appear objective and unbiased by commercial interests?

Question Title

* 24. As a moderator, Philip Mease, MD, was:

Question Title

* 25. Was the information in this activity relevant to your practice or professional development?

Question Title

* 26. I learned new information about SpA and PsA as a result of this program.

Question Title

* 27. Based on the information you received today, do you plan on changing your practice?

Question Title

* 28. How would you rate the presentation overall?

Question Title

* 29. Please let us know about any other comments you have: